
Antimicrobial Susceptibility of Neisseria gonorrhoeae Isolates in Yaoundé, Cameroon From 2009 to 2014
Author(s) -
Carolle Yanique Tayimetha,
Magnus Unemo
Publication year - 2018
Publication title -
sexually transmitted diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.507
H-Index - 105
eISSN - 1537-4521
pISSN - 0148-5717
DOI - 10.1097/olq.0000000000000915
Subject(s) - neisseria gonorrhoeae , medicine , ciprofloxacin , ceftriaxone , antibiotic resistance , antimicrobial , guideline , gonococcal infection , microbiology and biotechnology , antibiotics , gynecology , sexually transmitted disease , virology , syphilis , biology , human immunodeficiency virus (hiv) , pathology
We investigated the antimicrobial resistance in gonococci 2009 to 2014 in Yaoundé, Cameroon, and recommend revisions of the Cameroonian treatment guideline. We observed a high resistance to ciprofloxacin (17.6%) but no ceftriaxone resistance. Ceftriaxone should replace ciprofloxacin as the recommended first-line treatment for urethral/vaginal discharge. Enhanced resistance surveillance in Africa is essential.